AI assistant
Natco Pharma Ltd. — Call Transcript 2018
Nov 5, 2018
62741_rns_2018-11-05_0b726841-0c8a-4aac-87a7-551c8243f12e.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [452 x 46] intentionally omitted <==
November 5, 2018
Corporate Relationship Department M/s. BSE Limited Dalal Street, Fort, Mumbai 400 001
Manager - Listing M/s. National Stock Exchange of India Ltd “Exchange Plaza, Bandra – kurla complex, Bandra (E), Mumbai 400 051
Scrip Code: 524816
Scrip Code: NATCOPHARM
Dear Sir
Sub: - Earning call for the Quarter and half year ended September 30, 2018
The Company will host an Earnings Call with Investors / Analysts at 11.00 a.m. IST on November 6, 2018 to disseminate Financial Results of the company for the quarter and half year ended September 30, 2018. A Copy of the same is enclosed for your ready reference.
Thanking you
Yours faithfully For NATCO Pharma Limited
==> picture [106 x 23] intentionally omitted <==
M Adinarayana Company Secretary & Vice President (Legal & Corp. Affairs)
Encl: as above.
CONFERENCE CALL
NATCO PHARMA
==> picture [121 x 31] intentionally omitted <==
Hosted by Edelweiss Securities
India Equity Research October 31, 2018 2018
We are organising a conference call with the management of NATCO Pharma, to discuss the company’s Q2FY19 financial results on Tuesday, November 6, 2018 at 11.00 AM IST.
Mr. Rajeev Nannapaneni (Vice Chairman and Chief Executive Officer) and Mr. Rajesh Chebiyam (Vice President, Acquisitions, Institutional Investor Management and Corporate Communications) will represent NATCO Pharma on the call. The call would run for an hour.
Details of the conference call are as under:
| Time | : | 11.00 | AM IST on Tuesday, November 6, 2018 | |
|---|---|---|---|---|
| Conference | dial-in: | |||
| India | : | Mumbai | ||
| Primary access number | +91 22 6280 1123 | |||
| +91 22 7115 8024 | ||||
| USA | : | 1 866 746 2133 | ||
| UK | : | 0 808 101 1573 | ||
| Singapore Toll Free No. | : | 800 101 2045 | ||
| Hong Kong Toll Free No. | : | 800 964 448 | ||
| Call leader | Mr. Deepak Malik |
For further information please contact:
Deepak Malik
Edelweiss Securities Ltd. Tel.: +91 22 6620 3147 Fax: +91 22 2286 4310 E-mail: deepak.malik @edelweissfin.com
Edelweiss Research is also available on www.edelresearch.com, 1 Bloomberg EDEL , Thomson First Call, Reuters and Factset.
LimitedLimited